KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
002294 Shenzhen Salubris Pharmaceuticals
- 33.97
- -0.21-0.61%
Market Closed Dec 13 15:00 CST
37.87BMarket Cap61.99P/E (TTM)
34.25High33.42Low54.65KlotVolume34.10Open34.18Pre Close185.00MTurnover0.49%Turnover Ratio65.33P/E (Static)1.11BShares38.1052wk High4.40P/B37.86BFloat Cap23.0152wk Low37.60Limit Up1.11BShs Float43.66Historical High30.76Limit Down2.43%Amplitude0.46Historical Low0.50Dividend TTM33.85Avg Price27.99KlotAsk1.47%Div YieldTTM100Lot Size23.73KlotBid
Shenzhen Salubris Pharmaceuticals Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 22.18%3B | 21.28%2.04B | 22.92%1.09B | -3.35%3.37B | -3.61%2.46B | 0.97%1.68B | -5.10%887.51M | 13.85%3.48B | 16.50%2.55B | 21.20%1.67B |
| Operating revenue | 22.18%3B | 21.28%2.04B | 22.92%1.09B | -3.35%3.37B | -3.61%2.46B | 0.97%1.68B | -5.10%887.51M | 13.85%3.48B | 16.50%2.55B | 21.20%1.67B |
| Other operating revenue | ---- | 55.31%40.48M | ---- | 5.42%85.67M | ---- | 22.76%26.06M | ---- | 109.85%81.27M | ---- | 182.85%21.23M |
| Total operating cost | 25.89%2.46B | 26.52%1.67B | 29.96%870.65M | -1.51%2.76B | -2.96%1.95B | -2.06%1.32B | -7.56%669.92M | 11.83%2.8B | 18.22%2.01B | 24.68%1.35B |
| Operating cost | 6.86%838.28M | 12.72%589.79M | 20.77%311.45M | 6.44%1.06B | 19.16%784.45M | 25.23%523.25M | 10.60%257.88M | 25.25%993.61M | 17.51%658.33M | 12.68%417.84M |
| Operating tax surcharges | 10.66%38.53M | 1.42%25.76M | 17.16%14.34M | -7.19%43.56M | -5.83%34.82M | 5.89%25.4M | -10.05%12.24M | 4.35%46.93M | 10.81%36.97M | 18.37%23.99M |
| Operating expense | 53.65%1.1B | 44.24%740.8M | 37.31%377.04M | -7.20%1.02B | -16.63%715.74M | -13.03%513.58M | -17.05%274.59M | 5.65%1.09B | 23.73%858.53M | 42.99%590.53M |
| Administration expense | -5.66%196.64M | 1.76%133.69M | 11.80%71.61M | 20.64%286.59M | 8.03%208.43M | 2.69%131.37M | -0.09%64.05M | -21.89%237.56M | -10.52%192.94M | -13.12%127.93M |
| Financial expense | 52.47%-22.9M | 43.11%-20.92M | 30.14%-11.37M | 48.98%-53.78M | 48.78%-48.18M | 35.44%-36.77M | -32.73%-16.27M | -240.08%-105.41M | -480.04%-94.08M | -2,455.74%-56.95M |
| -Interest expense (Financial expense) | -12.10%12.16M | -11.35%7.83M | -8.25%3.95M | 38.55%17.37M | 87.39%13.84M | 230.16%8.83M | 392.71%4.31M | 19.11%12.54M | -11.49%7.38M | -61.40%2.67M |
| -Interest Income (Financial expense) | 30.11%-39.8M | 29.60%-27.75M | 23.89%-15.22M | 39.15%-68.64M | 36.91%-56.95M | 27.40%-39.42M | -69.77%-19.99M | -136.68%-112.8M | -189.98%-90.27M | -597.95%-54.29M |
| Research and development | 19.59%306.48M | 23.15%202.28M | 38.95%107.58M | -23.34%409.19M | -28.48%256.28M | -33.09%164.25M | -18.56%77.42M | 49.36%533.75M | 67.29%358.34M | 91.65%245.48M |
| Credit Impairment Loss | 36.23%-7.05M | 29.59%-8.03M | -1,004.39%-31.35K | -157.89%-2.42M | -301.99%-11.06M | -318.55%-11.4M | 133.11%3.47K | 154.78%4.18M | 268.43%5.48M | 370.14%5.22M |
| Asset Impairment Loss | -266.55%-19.03M | -613.37%-7.9M | ---5.07M | -3.23%-58.55M | -87.13%-5.19M | 60.27%-1.11M | ---- | 61.48%-56.72M | 87.07%-2.77M | -34,260.43%-2.79M |
| Other net revenue | -26.97%37.47M | -0.17%30.71M | -50.53%12.77M | 6.55%49.33M | -41.62%51.31M | -59.67%30.77M | -59.32%25.81M | 42.70%46.3M | 393.27%87.9M | 1,454.32%76.28M |
| Fair value change income | 21.16%7.92M | 1.47%5.39M | -56.32%1.47M | 112.34%8.09M | --6.53M | --5.31M | --3.37M | --3.81M | ---- | ---- |
| Invest income | 1,468.66%12.05M | 46.12%6.54M | 32.90%1.23M | -68.03%12.3M | -98.15%767.87K | -89.47%4.47M | -97.93%926.72K | -71.35%38.46M | 183.50%41.49M | 268.69%42.51M |
| -Including: Investment income associates | 17.89%-12M | -66.71%-10.03M | -64.27%-6.51M | -154.60%-15.46M | -411.45%-14.61M | -252.49%-6.02M | -2,391.10%-3.96M | 90.16%-6.07M | 90.84%-2.86M | 95.24%-1.71M |
| Asset deal income | 176.28%285.89K | 94.41%-20.93K | 94.70%-21.34K | -162.13%-477.67K | -35.22%-374.77K | -70.38%-374.52K | -522.00%-402.19K | 85.94%-182.23K | 78.42%-277.15K | -248.83%-219.82K |
| Other revenue | -28.58%43.31M | 2.57%34.73M | -30.68%15.19M | 59.25%90.39M | 37.86%60.64M | 7.28%33.86M | 16.05%21.91M | 4.36%56.76M | -3.75%43.98M | 47.79%31.56M |
| Operating profit | 4.62%581.77M | 2.02%401.95M | -4.24%233.09M | -9.82%655.98M | -11.06%556.08M | -0.42%393.98M | -11.15%243.41M | 24.09%727.44M | 36.98%625.2M | 36.96%395.63M |
| Add:Non operating Income | -74.40%186.87K | -86.24%72.61K | -87.83%15.21K | 0.29%1.88M | -25.25%730.1K | -38.55%527.7K | 41.28%124.93K | -93.37%1.88M | -96.32%976.74K | 72.34%858.8K |
| Less:Non operating expense | 11.93%7.67M | 75.51%5.18M | 58.23%2.37M | 3.27%16.1M | -46.47%6.85M | -66.20%2.95M | -76.00%1.5M | 5.99%15.59M | 24.79%12.8M | 36.21%8.72M |
| Total profit | 4.42%574.29M | 1.35%396.85M | -4.67%230.73M | -10.08%641.76M | -10.34%549.96M | 0.98%391.56M | -9.62%242.04M | 18.99%713.73M | 29.75%613.38M | 37.03%387.76M |
| Less:Income tax cost | -14.52%62.2M | -5.77%52.55M | -2.15%32.62M | -23.22%60.93M | -3.02%72.77M | 38.11%55.76M | 7.73%33.34M | 10.96%79.36M | -11.80%75.04M | -21.14%40.38M |
| Net profit | 7.31%512.09M | 2.53%344.3M | -5.07%198.11M | -8.44%580.83M | -11.36%477.19M | -3.34%335.79M | -11.89%208.7M | 20.07%634.37M | 38.87%538.34M | 49.89%347.38M |
| Net profit from continuing operation | 7.31%512.09M | 2.53%344.3M | -5.07%198.11M | -8.44%580.83M | -11.36%477.19M | -3.34%335.79M | -11.89%208.7M | 20.07%634.37M | 38.87%538.34M | 49.89%347.38M |
| Less:Minority Profit | 219.85%2.37M | 111.29%206.84K | 4.41%-2.15M | 127.97%762.47K | -54.81%-1.98M | -124.95%-1.83M | -302.87%-2.25M | 49.57%-2.73M | 70.14%-1.28M | 84.23%-814.79K |
| Net profit of parent company owners | 6.37%509.71M | 1.92%344.09M | -5.06%200.27M | -8.95%580.07M | -11.20%479.17M | -3.04%337.62M | -11.15%210.95M | 19.37%637.09M | 37.68%539.62M | 46.96%348.2M |
| Earning per share | ||||||||||
| Basic earning per share | 6.98%0.46 | 3.33%0.31 | -5.26%0.18 | -10.34%0.52 | -12.24%0.43 | -3.23%0.3 | -13.64%0.19 | 16.00%0.58 | 28.95%0.49 | 40.91%0.31 |
| Diluted earning per share | 6.98%0.46 | 3.33%0.31 | -5.26%0.18 | -10.34%0.52 | -12.24%0.43 | -3.23%0.3 | -13.64%0.19 | 16.00%0.58 | 28.95%0.49 | 40.91%0.31 |
| Other composite income | -139.43%-6.07M | -84.71%2.84M | 107.70%600.42K | -77.40%10.55M | -71.29%15.4M | -22.78%18.61M | -114.18%-7.8M | 915.53%46.66M | 506.38%53.64M | 333.57%24.09M |
| Other composite income of parent company owners | -139.43%-6.07M | -84.71%2.84M | 107.70%600.42K | -77.74%10.39M | -71.29%15.4M | -22.78%18.61M | -114.18%-7.8M | 915.53%46.66M | 506.38%53.64M | 333.57%24.09M |
| Other composite income of minority owners | ---- | ---- | ---- | --160.79K | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | 2.73%506.02M | -2.05%347.14M | -1.09%198.71M | -13.16%591.37M | -16.79%492.59M | -4.60%354.4M | -13.86%200.9M | 30.31%681.02M | 49.30%591.98M | 56.53%371.48M |
| Total composite income of parent company owners | 1.83%503.64M | -2.61%346.94M | -1.12%200.87M | -13.64%590.45M | -16.63%494.57M | -4.31%356.23M | -13.10%203.15M | 29.50%683.75M | 48.02%593.26M | 53.53%372.29M |
| Total composite income of minority owners | 219.85%2.37M | 111.29%206.84K | 4.41%-2.15M | 133.87%923.26K | -54.81%-1.98M | -124.95%-1.83M | -302.87%-2.25M | 49.57%-2.73M | 70.14%-1.28M | 84.23%-814.79K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
